Skip to main content

NIH Extramural Clinical Research: Internal Controls Are Key to Safeguarding Phase III Trials Against Misconduct

HEHS-96-117 Published: Jul 11, 1996. Publicly Released: Jul 11, 1996.
Jump To:

Highlights

Pursuant to a congressional request, GAO reviewed the National Institutes of Health's (NIH) oversight of the clinical trials it sponsors, focusing on NIH internal controls to prevent misuse of federal funds and safeguard the integrity of clinical trial data.

Full Report

Full Report (26 pages)

Media Inquiries

Sarah Kaczmarek
Managing Director
Office of Public Affairs
media@gao.gov

Topics

Health Care
Cancer researchData integrityEthical conductFederal fundsFinancial managementHealth research programsInternal controlsMedical researchResearch grantsResearch program management